Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
MA26.03 Activity of Osimertinib and the Selective RET Inhibitor BLU-667 in an EGFR-Mutant Patient with Acquired RET Rearrangement
PaperCitations, authors & open-access status
MA26.03 Activity of Osimertinib and the Selective RET Inhibitor BLU-667 in an EGFR-Mutant Patient with Acquired RET Rearrangement is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1 citations, 2018 year and bronze oa status.
1
Citations
2018
Year
bronze
OA Status